LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Abstract 5940: Enhanced mast cell abundance is associated with the enrichment of CCR2+ cytotoxic T cells and favorable prognosis in lung adenocarcinoma

Photo by impulsq from unsplash

Mast cells constitute indispensably immunoregulatory sentinel cells in tumor microenvironment, however, their functions are poorly characterized in lung adenocarcinoma (LUAD). Here, we performed flow cytometry and single-cell RNA sequencing to… Click to show full abstract

Mast cells constitute indispensably immunoregulatory sentinel cells in tumor microenvironment, however, their functions are poorly characterized in lung adenocarcinoma (LUAD). Here, we performed flow cytometry and single-cell RNA sequencing to comprehensively characterize LUAD infiltrating MCs. MCs exhibited remarkably functional heterogeneity and were enriched in ground-glass opacity featured LUAD (gLUAD). The MCs in gLUAD exhibited proinflammatory and chemotactic properties while the MCs in radiologically solid LUAD (sLUAD) were associated with tumor angiogenesis. MCs were an important source of CCL2 that correlated with the recruitment of CCR2+ cytotoxic T lymphocytes (CTLs), which represent a specific subcluster of pre-exhausted T cells with tissue-resident memory phenotype and enhanced cytotoxicity. Increased infiltration of MCs-CCR2+ CTLs and their colocalization showed a strong association with favorable prognosis after surgery but were not associated with improved survival after chemotherapy. Collectively, these findings reveal a key role of MCs in LUAD and their potential crosstalk with CTLs, suggesting that targeting MCs may be a novel immunotherapeutic strategy for LUAD. Citation Format: Fan Fan, Xiaoming Zhang, Haiquan Chen. Enhanced mast cell abundance is associated with the enrichment of CCR2+ cytotoxic T cells and favorable prognosis in lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5940.

Keywords: lung adenocarcinoma; ccr2; favorable prognosis; mast; mcs; ccr2 cytotoxic

Journal Title: Cancer Research
Year Published: 2023

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.